DEXCOM, INC. (DXCM) FY2026 Q2 Balance Sheet
As of 2026-06-30
Balance Sheet
As of 2026-06-30
Swipe to see the full flow
Chart details
DEXCOM, INC. (DXCM) FY2026 Q2 Balance Sheet
Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.
- Assets
- 6,455,300,000 US dollars
- Current assets
- 4,086,600,000 US dollars
- Non-current assets
- 2,368,700,000 US dollars
- Liabilities
- 3,833,900,000 US dollars
- Current liabilities
- 2,357,700,000 US dollars
- Non-current liabilities
- 1,476,200,000 US dollars
- Equity
- 2,621,400,000 US dollars
- Accounts receivable, net
- 1,257,700,000 US dollars
- Cash and cash equivalents
- 1,105,000,000 US dollars
- Short-term marketable securities
- 842,000,000 US dollars
- Inventory
- 726,400,000 US dollars
- Prepaid and other current assets
- 155,500,000 US dollars
- Property and equipment, net
- 1,577,200,000 US dollars
- Deferred tax assets
- 304,100,000 US dollars
- Other assets
- 273,700,000 US dollars
- Intangibles, net
- 101,600,000 US dollars
- Operating lease right-of-use assets
- 88,000,000 US dollars
- Goodwill
- 24,100,000 US dollars
- Accounts payable and accrued liabilities
- 2,191,500,000 US dollars
- Accrued payroll and related expenses
- 136,300,000 US dollars
- Short-term operating lease liabilities
- 20,700,000 US dollars
- Other current liabilities
- 9,200,000 US dollars
- Long-term senior convertible notes
- 1,242,800,000 US dollars
- Other long-term liabilities
- 150,800,000 US dollars
- Long-term operating lease liabilities
- 82,600,000 US dollars
- Retained earnings
- 2,882,500,000 US dollars
- Additional paid-in capital
- 2,376,500,000 US dollars
- Accumulated other comprehensive income
- 90,000,000 US dollars
- Common stock, $0.001 par value, 800.0 million shares authorized; 412.4 million and 377.4 million shares issued and outstanding, respectively, at June 30, 2026; and 410.7 million and 384.8 million shares issued and outstanding, respectively, at December 31, 2025
- 400,000 US dollars
- Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at June 30, 2026 and December 31, 2025
- 0 US dollars
- Treasury stock, at cost; 35.0 million shares at June 30, 2026 and 25.9 million shares at December 31, 2025
- negative 2,728,000,000 US dollars
- Gross equity (calculated)
- 5,349,400,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
